In this video, health-care analysts David Williamson and Max Macaluso discuss four big headlines impacting some of the most popular stocks in the space. Watch and find out what it all means for investors.
The biotech space can make or destroy investors overnight, and Amarin, with its potential blockbuster drug, will be no different. The company has huge potential, but don't invest today before reading everything you need to know about Amarin. You can start now with top Fool.com analyst Max Macaluso's premium research report. Click here to keep reading.
RSS Headlines
Fool UK
Comments from our Foolish Readers
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the
Report this Comment icon found on every comment.
Be the first one to comment on this article.